https://www.novartis.com/us-en/ 2026-03-05T11:34:50-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/victor-bulto 2025-10-22T11:50:24-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/sonia-choi 2025-10-22T11:50:12-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/des-creary 2025-10-22T11:50:00-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/javier-gesualdo 2025-10-22T11:49:43-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/gail-horwood 2025-10-22T11:49:33-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/reshema-kemps-polanco 2026-01-30T15:45:20-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/shefali-kothari 2025-10-22T11:49:09-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/katie-mazuk 2025-10-22T13:35:11-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/elizabeth-mcgee 2025-10-22T11:48:46-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/melissa-mckerracher 2025-10-22T11:48:31-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/liviu-niculescu 2025-11-19T14:27:37-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/courtney-piron 2026-01-02T09:41:19-05:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/vicki-rawlinson 2025-10-22T11:47:53-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/rob-rubinsky 2025-10-22T11:47:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team/eden-wells 2025-11-17T13:55:28-05:00 daily 1.0 https://www.novartis.com/us-en/page-not-found 2022-03-30T01:06:54-04:00 daily 1.0 https://www.novartis.com/us-en/news/news-archive 2024-03-26T10:29:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers 2026-03-05T14:26:50-05:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/novartis-commitment-patients-and-caregivers 2025-04-25T14:06:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior 2024-03-26T09:33:56-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/code-ethics 2025-10-06T10:48:38-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/speakup 2025-12-17T17:25:45-05:00 daily 1.0 https://www.novartis.com/us-en/terms-use 2024-03-27T09:34:26-04:00 daily 1.0 https://www.novartis.com/us-en/careers/awards-recognition 2025-02-08T23:18:05-05:00 daily 1.0 https://www.novartis.com/us-en/careers/employee-benefits 2025-04-25T13:56:35-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-support 2025-11-11T11:56:34-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/people-and-communities 2024-03-26T10:15:18-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/business-principles 2024-03-26T09:42:26-04:00 daily 1.0 https://www.novartis.com/us-en/esg/environmental-sustainability 2025-01-29T11:43:09-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/compliance-program 2025-07-02T09:57:58-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws 2025-06-25T11:51:17-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethical-behavior/phrma-code-interactions-healthcare-professionals 2024-03-26T09:39:51-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/payments-hcps-hcos 2022-03-28T12:02:01-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/patient-assistance-foundation-enrollment 2024-09-30T17:26:40-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/ca-health-and-safety-code-ss119402 2025-06-25T11:51:37-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/annual-description-comprehensive-compliance-program 2025-06-25T11:52:03-04:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/california-npc-declaration-compliance 2025-06-25T11:52:22-04:00 daily 1.0 https://www.novartis.com/us-en/news/us-media-contacts 2025-01-08T13:48:58-05:00 daily 1.0 https://www.novartis.com/us-en/contact-select 2025-10-17T12:16:10-04:00 daily 1.0 https://www.novartis.com/us-en/careers/nibr-careers-frequently-asked-questions 2022-03-13T11:21:01-04:00 daily 1.0 https://www.novartis.com/us-en/recall-zofran-and-entresto-packages 2025-01-30T03:47:16-05:00 daily 1.0 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/drug-supply-chain-security-act-information 2025-01-30T03:49:14-05:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-society-integrated-report 2025-02-10T10:01:00-05:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/company-glance/value-and-pricing 2022-03-28T12:51:24-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-us-foundation 2022-03-28T13:05:34-04:00 daily 1.0 https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers 2022-03-25T09:37:33-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance 2025-04-25T14:04:43-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding-healthcare-professionals 2025-04-25T14:02:42-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants 2022-05-17T11:18:02-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/sponsorships-and-memberships 2025-05-13T12:02:12-04:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/faqs 2025-03-05T11:40:10-05:00 daily 1.0 https://www.novartis.com/us-en/healthcare-professionals/external-funding/educational-grants/professional-medical-education-grants 2026-02-24T16:19:47-05:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/patient-education-grants 2022-05-17T11:27:15-04:00 daily 1.0 https://www.novartis.com/us-en/about/inclusion-and-belonging/supplier-innovation-development 2026-02-04T13:07:58-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-research 2024-10-29T03:05:19-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-digital 2025-01-24T09:37:59-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-information-technology-it 2025-01-24T09:40:08-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-procurement 2024-10-29T03:06:16-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-health-safety-environment 2024-10-29T03:07:09-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-medical-development 2025-01-24T09:38:36-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-people-organization 2025-01-24T09:38:47-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-communications-and-advocacy 2022-03-29T03:38:49-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-consulting 2025-01-24T09:39:32-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-technical-operations 2023-11-13T07:49:07-05:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-strategy 2022-03-29T03:13:12-04:00 daily 1.0 https://www.novartis.com/us-en/careers/meet-teams/careers-commercial 2024-10-29T03:08:16-04:00 daily 1.0 https://www.novartis.com/us-en/news/step-program/age-related-macular-degeneration-amd 2022-03-28T10:07:02-04:00 daily 1.0 https://www.novartis.com/us-en/careers/early-talent 2025-04-25T13:59:01-04:00 daily 1.0 https://www.novartis.com/us-en/about/contact-us 2025-10-17T12:17:31-04:00 daily 1.0 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope/beacon-hope-solutions-improving-access-healthcare 2025-06-13T11:51:01-04:00 daily 1.0 https://www.novartis.com/us-en/gilenya-guides-community-privacy-policy 2022-07-22T15:01:14-04:00 daily 1.0 https://www.novartis.com/us-en/privacy 2025-10-23T03:38:12-04:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-01-20T12:59:44-05:00 daily 1.0 https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-hyperlipidemia 2023-01-20T12:58:36-05:00 daily 1.0 https://www.novartis.com/us-en/news/radioligand-therapy-supply-information/patient-faqs 2023-06-02T12:52:01-04:00 daily 1.0 https://www.novartis.com/us-en/esg/beacon-hope/paving-way-brighter-more-equitable-future 2024-03-26T10:24:51-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/chronic-spontaneous-urticaria-csu 2025-10-07T14:03:45-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/hidradenitis-suppurativa-hs 2025-04-25T13:53:19-04:00 daily 1.0 https://www.novartis.com/us-en/privacy/consumer-health 2025-10-23T03:52:29-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/prostate-cancer 2025-12-11T10:58:02-05:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/paroxysmal-nocturnal-hemoglobinuria-pnh 2025-04-25T13:51:44-04:00 daily 1.0 https://www.novartis.com/us-en/external-support-0 2025-09-26T16:54:43-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/breast-cancer 2025-10-09T09:49:45-04:00 daily 1.0 https://www.novartis.com/us-en/patients-and-caregivers/diseases/sjogrens-disease 2025-10-21T09:10:27-04:00 daily 1.0 https://www.novartis.com/us-en/about/leadership-team 2026-01-02T09:40:11-05:00 daily 1.0 https://www.novartis.com/us-en/text-message-communications-terms-conditions 2026-01-09T08:54:42-05:00 daily 1.0 https://www.novartis.com/us-en/news 2026-03-05T15:04:13-05:00 daily 0.5 https://www.novartis.com/us-en/about 2026-03-05T13:01:25-05:00 daily 0.5 https://www.novartis.com/us-en/home 2026-03-05T11:34:50-05:00 daily 0.5 https://www.novartis.com/us-en/esg 2026-03-05T13:14:51-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers 2026-03-05T15:06:06-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals 2026-03-05T15:02:28-05:00 daily 0.5 https://www.novartis.com/us-en/about/inclusion-and-belonging 2026-02-04T14:39:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/novartis-us 2026-03-05T04:27:14-05:00 daily 0.5 https://www.novartis.com/us-en/esg/ethics-risk-and-compliance 2025-01-30T06:27:39-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility 2025-02-20T10:41:29-05:00 daily 0.5 https://www.novartis.com/us-en/esg/corporate-responsibility/beacon-hope 2025-06-13T11:49:58-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/cardio-renal-metabolism/renal/NCT04181762-us-en 2026-03-05T04:29:45-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/respiratory-allergy/foodallergy/NCT04984876-us-es 2026-03-05T04:43:59-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/SLE/NCT05639114-NCT05624749 2025-06-25T12:18:01-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/osteoarthritis/NCT04886258-NCT04814368-NCT05462990-es 2026-03-05T04:45:21-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/RCT/NCT05722522-NCT05758415 2026-03-05T04:46:43-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/LN/NCT05126277 2026-03-05T04:47:56-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/diseases 2026-03-05T04:48:50-05:00 daily 0.5 https://www.novartis.com/us-en/patients-and-caregivers/patient-resources 2025-12-09T16:40:59-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/hcp-resources 2025-07-21T14:05:01-04:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/immunology/CINDU/NCT05976243 2025-01-31T11:35:31-05:00 daily 0.5 https://www.novartis.com/us-en/clinicaltrials/hematology/ITPWAIHA/NCT05653349-NCT05653219-NCT05648968-us-es 2026-03-05T04:50:11-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/personalized-and-precision-medicine 2026-01-27T15:13:45-05:00 daily 0.5 https://www.novartis.com/us-en/healthcare-professionals/health-information-technology-resources 2026-03-04T16:11:13-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas 2026-03-05T04:51:33-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/oncology 2026-01-30T11:02:52-05:00 daily 0.5 https://www.novartis.com/us-en/about/nfl-partnership 2026-02-12T15:28:29-05:00 daily 0.5 https://www.novartis.com/us-en/about/investing-americas-health 2026-03-05T14:23:44-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/immunology 2026-03-05T04:54:43-05:00 daily 0.5 https://www.novartis.com/us-en/cardiovascular-disease 2026-03-05T12:05:43-05:00 daily 0.5 https://www.novartis.com/us-en/about/therapeutic-areas/cardiovascular-renal 2026-03-05T04:57:33-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-corrective-action-certain-blister-packages-sandimmune-and-neoral-100-mg-soft-gelatin-capsules-us-due-failure-meet-child-resistant-packaging-requirements 2022-04-04T03:14:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy 2022-04-04T03:09:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-04-04T02:24:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction 2022-03-13T11:20:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-novartis-us-foundation-establish-usd-5-million-us-covid-19-community-response-fund 2022-07-25T11:29:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities 2022-03-29T04:00:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14 2022-03-29T08:12:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease 2022-03-29T03:57:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms 2022-03-29T08:15:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery 2022-03-29T08:18:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information 2022-03-29T08:20:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-manufactures-and-donates-27000-units-hand-sanitizer-new-york-state 2022-03-29T08:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis 2022-03-29T08:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ilaris-canakinumab-receives-fda-approval-new-indication-treat-adult-onset-stills-disease-aosd 2022-03-29T08:31:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-entresto-sacubitrilvalsartan-patients-heart-failure-preserved-ejection-fraction-hfpef 2022-03-29T08:34:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis 2022-03-29T08:00:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications 2022-03-29T09:10:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis 2022-03-29T08:38:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper 2022-03-29T08:39:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-parallax-data-provides-further-evidence-potential-benefit-entresto-patients-hfpef 2022-03-29T08:41:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran 2022-03-29T08:42:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-effects-treatment-mayzent-siponimod-studied-disability-progression-and-cognitive-processing-speed-patients-progressing-relapsing-multiple-sclerosis 2022-03-29T08:43:42-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis 2022-03-29T08:45:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us 2022-03-29T08:48:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-awards-nearly-375000-patient-advocacy-organizations-their-innovative-solutions-biomarker-testing-now-accepting-proposals-caregiving-cancer-and-certain-blood-disorders 2022-03-29T08:51:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine 2022-03-29T09:07:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study 2022-03-29T08:59:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender 2022-03-29T09:02:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases 2022-03-29T09:05:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps 2022-03-29T09:10:21-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine 2022-03-29T10:13:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial 2022-03-29T10:09:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer 2022-03-29T10:15:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef 2022-03-29T10:37:59-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-idiopathic-urticaria-ciu 2022-03-29T10:34:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda 2022-07-25T11:38:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-awards-450000-eight-nonprofit-organizations-through-step-programtm 2022-03-29T10:48:05-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients 2022-03-29T10:50:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-aan-novel-combination-biomarker-may-predict-disability-worsening-secondary-progressive-multiple-sclerosis 2022-03-29T10:54:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms 2022-03-29T11:00:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-data-aad-vmx-shows-improvement-skin-symptoms-and-quality-life-was-maintained-one-year-children-moderate-severe-plaque-psoriasis 2022-03-29T11:00:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept 2022-03-29T11:06:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care 2022-03-29T11:05:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program 2022-03-29T10:09:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis 2022-03-29T10:09:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma 2022-03-29T10:08:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients 2022-03-29T10:08:44-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy 2022-03-29T10:08:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc 2022-03-29T10:07:50-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity 2022-03-29T10:19:17-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks 2022-03-29T10:16:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:31:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros 2022-03-29T10:34:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer 2022-03-29T10:38:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema 2022-03-29T10:58:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis 2022-03-29T11:02:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia 2022-03-29T11:09:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g 2022-03-29T11:13:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021 2022-03-29T11:20:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer 2022-03-29T11:27:32-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i 2022-03-29T11:32:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow 2022-03-29T11:37:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021 2022-03-29T11:33:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year 2022-07-21T12:09:56-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis 2022-03-29T11:25:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study 2022-03-29T11:20:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma 2022-07-07T10:23:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer 2022-07-07T10:23:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-0 2022-07-07T10:23:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment 2022-07-07T10:24:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps 2022-07-07T10:24:27-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace 2022-07-07T10:24:30-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum 2022-07-07T10:24:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home 2022-07-07T10:24:36-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist 2022-07-07T10:24:38-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma 2022-07-07T10:24:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination 2022-07-07T10:24:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd 2022-07-07T10:24:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients 2022-07-07T10:24:48-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease 2022-07-07T10:24:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers 2022-07-07T10:24:54-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community 2022-07-07T10:24:57-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah 2022-07-07T10:25:00-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study 2022-07-07T10:25:03-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis 2022-07-07T10:25:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance 2022-07-07T10:25:09-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community 2022-07-25T11:29:18-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis 2022-07-07T10:25:12-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer 2022-07-07T10:25:14-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention 2022-07-07T10:25:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis 2022-07-07T10:25:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color 2022-07-20T16:07:02-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval 2022-07-07T10:25:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:25:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa 2022-07-07T10:25:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study 2022-07-07T10:25:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer 2022-07-07T10:25:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness 2022-07-07T10:25:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a 2022-07-07T10:25:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign 2022-07-07T10:25:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis 2022-07-07T10:25:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl 2022-07-07T10:25:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl 2022-07-07T10:25:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause 2022-07-07T10:25:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all 2022-07-07T10:26:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones 2022-07-07T10:26:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients 2022-07-07T10:26:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma 2022-07-07T10:26:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms 2022-07-07T10:26:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes 2022-07-07T10:26:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net 2022-07-07T10:26:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all 2022-07-07T10:26:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows 2022-07-07T10:26:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease 2022-07-07T10:26:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist 2022-07-07T10:26:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan 2022-07-07T10:26:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma 2022-07-07T10:26:37-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload 2022-07-07T10:26:40-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara 2022-07-07T10:26:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review 2022-07-25T11:40:33-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder 2022-07-07T10:26:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients 2022-07-07T10:26:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm 2022-07-07T10:26:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial 2022-07-07T10:26:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients 2022-07-07T10:26:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers 2022-07-07T10:27:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients 2022-07-07T10:27:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia 2022-07-07T10:27:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease 2022-07-07T10:27:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha 2022-07-07T10:27:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies 2022-07-07T10:27:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:19-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder 2022-07-07T10:27:22-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer 2022-07-07T10:27:25-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease 2022-07-07T10:27:28-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis 2022-07-07T10:27:31-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review 2022-07-07T10:27:35-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims 2022-07-07T10:27:39-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis 2022-07-07T10:27:43-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial 2022-07-07T10:27:46-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease 2022-07-07T10:27:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net 2022-07-07T10:27:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products 2022-07-07T10:27:55-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities 2022-07-07T10:27:58-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression 2022-07-07T10:28:01-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court 2022-07-07T10:28:04-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill 2022-07-07T10:28:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together 2022-07-07T10:28:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer 2022-07-07T10:28:13-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia 2022-07-07T10:28:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments 2022-07-20T16:05:08-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting 2022-07-07T10:28:20-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure 2022-07-07T10:28:23-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release 2022-07-07T10:28:26-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release 2022-07-07T10:28:29-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-acquires-kedalion-therapeutics-and-its-innovative-ocular-delivery-platform-could-transform-patient-experience 2022-07-20T15:51:51-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab 2022-10-11T20:23:10-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-tafinlar-mekinist-approved-fda-pediatric-patients-braf-v600e-low-grade-glioma-most-common-pediatric-brain-cancer 2023-03-17T12:24:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-only-category-1-preferred-first-line-treatment-option-hrher2-mbc-combination-ai-updated-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2023-03-29T10:40:34-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan-0 2025-02-13T11:41:27-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-1 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2005-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/2004-release-0 2023-06-03T05:49:16-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups 2024-03-04T06:49:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-five-year-data-disability-outcomes-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-interim-analysis-demonstrating-clinically-meaningful-benefit-broad-population-patients-early-breast-cancer 2024-04-30T06:50:06-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-pivotal-phase-iii-apply-pnh-data-ash-demonstrating-investigational-oral-monotherapy-iptacopan-superiority-over-anti-c5 2024-01-25T07:04:35-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-investigational-iptacopan-provides-clinically-meaningful-increases-hemoglobin-levels-complement-inhibitor-naive-patients-pnh 2024-02-11T06:49:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-prolonged-pfs-benefit-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-scientific-advances-kisqali-iptacopan-scemblix-and-ytb323-data-sabcs-and-ash 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-beacon-hope-through-alliances-historically-black-medical-schools-address-systemic-health-disparities 2023-12-14T06:50:05-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-premieres-powerful-new-docuseries-tribeca-festival-shine-light-debilitating-skin-disease 2024-04-14T06:49:52-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/us-fda-approves-expanded-indication-novartis-leqvio-inclisiran-include-treatment-adults-high-ldl-c-and-who-are-increased-risk-heart-disease 2024-04-16T09:49:49-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-strengthens-commitment-beacon-hope-initiative-engages-new-collaborators-support-clinical-trial-diversity-break-down-economic-and-education-barriers 2025-02-08T22:41:48-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-one-lot-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-28T13:35:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-intravenous-iv-formulation-interleukin-17a-antagonist-rheumatic-diseases 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvicto-shows-clinically-meaningful-and-highly-statistically-significant-rpfs-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer-pre-taxane-setting 2024-01-08T05:50:07-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-confirms-unconstrained-supply-pluvicto-and-continues-significantly-expand-number-treatment-centers 2023-10-26T17:47:07-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade 2023-12-28T13:50:04-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-us-nationwide-recall-two-lots-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization 2023-12-04T06:36:01-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-fabhalta-iptacopan-offering-superior-hemoglobin-improvement-absence-transfusions-first-oral-monotherapy-adults-pnh 2023-12-06T00:35:53-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-risk-recurrence-across-broad-population-patients-early-breast-cancer-supports-regulatory-submissions 2024-03-27T06:50:24-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-48-week-results-from-phase-iii-apply-pnh-trial-showing-sustained-efficacy-and-long-term-safety-fabhalta-iptacopan-adults-paroxysmal-nocturnal-hemoglobinuria-pnh 2023-12-10T20:05:58-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-expands-production-pluvicto-addition-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-indianapolis 2024-01-05T09:50:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-lutathera-significantly-reduced-risk-disease-progression-or-death-72-first-line-treatment-patients-advanced-gastroenteropancreatic-neuroendocrine-tumors 2024-01-19T10:19:32-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-xolair-omalizumab-first-and-only-medicine-children-and-adults-one-or-more-food-allergies 2024-02-16T11:34:40-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-england-journal-medicine-publishes-phase-iii-data-showing-xolair-omalizumab-significantly-reduced-allergic-reactions-across-multiple-foods-people-food-allergies 2024-02-25T14:04:54-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-plans-expand-its-us-based-manufacturing-and-rd-footprint-total-investment-23b-over-next-5-years 2025-10-23T03:37:47-04:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan 2025-11-10T10:28:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-plans-build-flagship-manufacturing-hub-north-carolina 2025-11-19T12:35:44-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-flagship-manufacturing-hub-north-carolina 2025-12-15T03:31:37-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-and-us-government-reach-agreement-lowering-drug-prices-us 2025-12-19T14:35:39-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-add-radioligand-therapy-manufacturing-facility-winter-park-florida-fourth-us-serve-patients-and-advance-23-billion-investment 2026-01-09T10:32:25-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-breaks-ground-new-global-biomedical-research-center-san-diego-accelerate-drug-discovery 2026-02-06T12:03:31-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-build-new-radioligand-therapy-site-denton-texas-delivering-more-next-generation-treatments-patients 2026-02-25T07:05:41-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-real-world-data-reinforce-earlier-use-pluvicto-chemotherapy-metastatic-castration-resistant-prostate-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-rhapsido-remibrutinib-data-aaaai-showing-potential-beyond-chronic-spontaneous-urticaria-csu 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-remibrutinib-first-therapy-achieve-phase-iii-primary-endpoint-chronic-inducible-urticaria-cindu 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-vanrafia-phase-iii-data-support-slowing-kidney-function-decline-patients-iga-nephropathy 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/nfl-greats-and-novartis-tackle-prostate-cancer-myths-super-bowl-lx-relax-its-blood-test 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-disease 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-significantly-extends-disease-control-patients-immune-thrombocytopenia-only-four-once-monthly-doses 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/1-4-metastatic-breast-cancer-patients-treated-novartis-kisqali-remain-progression-free-beyond-4-years 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-underscore-pioneering-scientific-innovation-hematology-and-oncology-ash-and-sabcs 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-itvisma-only-gene-replacement-therapy-children-two-years-and-older-teens-and-adults-spinal-muscular-atrophy-sma 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asn-kidney-week-and-aha-scientific-sessions-demonstrate-momentum-broad-crm-portfolio-and-pipeline 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-first-drug-reduce-disease-activity-and-patient-burden-sjogrens-disease-phase-iii-trials 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-showcases-significant-immunology-advancements-acr-congress-new-data-complex-autoimmune-diseases 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-meets-primary-and-all-secondary-endpoints-phase-iii-trial-patients-polymyalgia-rheumatica-pmr 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/psmaddition-data-show-novartis-pluvictotm-delays-progression-end-stage-prostate-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-5-year-natalee-data-demonstrate-28-reduction-risk-recurrence-broadest-early-breast-cancer-patient-population 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-fabhalta-iptacopan-meets-phase-iii-primary-endpoint-slows-kidney-function-decline-patients-iga-nephropathy-igan 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-rhapsido-remibrutinib-only-oral-targeted-btki-treatment-chronic-spontaneous-urticaria-csu 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-launch-direct-patient-platform-cosentyx-secukinumab-us 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-further-support-benefits-kesimpta-relapsing-ms-following-switch-from-oral-disease-modifying-therapies 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ianalumab-phase-iii-trial-meets-primary-endpoint-itp-demonstrating-statistically-significant-improvement-time-treatment-failure 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-announces-both-ianalumab-phase-iii-clinical-trials-met-primary-endpoint-patients-sjogrens-disease 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-twice-yearly-leqvio-inclisiran-receives-fda-approval-new-indication-enabling-first-line-use 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-provides-update-phase-iii-gcaptain-study-cosentyx-giant-cell-arteritis-gca 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reduces-risk-recurrence-younger-patients-early-breast-cancer-natalee-subgroup-analysis 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-asco-and-eha-showcase-momentum-pioneering-portfolio-promising-pipeline 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-vanrafia-atrasentan-first-and-only-selective-endothelin-receptor-antagonist-proteinuria-reduction-primary-iga-nephropathy-igan 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-present-new-data-aan-including-seven-year-disability-outcomes-and-safety-analysis-kesimpta-people-relapsing-multiple-sclerosis 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-third-fda-approval-oral-fabhalta-iptacopan-first-and-only-treatment-approved-c3-glomerulopathy-c3g 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-named-first-ever-corporate-pharmaceutical-partner-national-football-league 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-data-presentations-aaaai-and-aad-underscore-commitment-advancing-treatment-hidradenitis-suppurativa-hs-and-chronic-spontaneous-urticaria-csu 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/early-detection-game-changer-novartis-makes-bold-play-prioritize-breast-health-and-inspire-new-wave-breast-cancer-screenings 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-oral-fabhalta-iptacopan-sustained-clinically-meaningful-results-one-year-phase-iii-c3-glomerulopathy-c3g-trial 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-recognized-category-1-preferred-breast-cancer-adjuvant-treatment-nccn-clinical-practice-guidelines-oncology-nccn-guidelines 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-positive-chmp-opinion-kisqali-help-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-relapsing-ms-reinforce-benefits-kesimpta-first-line-and-switch-patients 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kisqali-reduce-risk-recurrence-people-hrher2-early-breast-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-deepening-benefit-new-analysis-reducing-risk-recurrence-285-broad-population-patients-early-breast-cancer 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-begins-construction-two-new-radioligand-therapy-facilities-us-expanding-its-world-class-rlt-manufacturing-and-supply-network 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-accelerated-approval-fabhalta-iptacopan-first-and-only-complement-inhibitor-reduction-proteinuria-primary-iga-nephropathy-igan 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-granted-fda-priority-review-treatment-adults-newly-diagnosed-cml 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-phase-iii-data-first-show-superior-efficacy-favorable-safety-and-tolerability-profile-vs-standard-care-tkis-adults-newly-diagnosed-cml 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/latest-analysis-novartis-natalee-study-shows-kisqali-reduces-risk-cancer-recurrence-early-breast-cancer-patients-high-risk-node-negative-disease 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-atrasentan-phase-iii-data-show-clinically-meaningful-proteinuria-reduction-further-advancing-companys-iga-nephropathy-igan-portfolio 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-presents-latest-phase-iii-fabhalta-iptacopan-data-c3-glomerulopathy-c3g-showing-clinically-meaningful-and-statistically-significant-351-proteinuria-reduction-vs-placebo 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-highlights-pioneering-innovation-cml-data-from-scemblix-phase-iii-asc4first-study-newly-diagnosed-patients-asco-and-eha 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/novartis-kesimpta-six-year-efficacy-data-show-substantial-benefits-recently-diagnosed-treatment-naive-people-relapsing-multiple-sclerosis 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-fabhalta-iptacopan-data-show-clinically-meaningful-and-statistically-significant-proteinuria-reduction-383-versus-placebo-patients-iga-nephropathy-igan 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-early-addition-twice-yearly-leqvio-inclisiran-following-maximally-tolerated-statin-therapy-significantly-reduces-ldl-c-ascvd-patients-real-world-setting 2026-03-03T11:06:09-05:00 daily 0.5 https://www.novartis.com/us-en/news/novartis-launches-new-preferred-firm-program-legal-services 2023-11-30T11:04:46-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-pharmaceuticals-corporation-novartis-statement-recall-outside-united-states-sandoz-generic-valsartan-and-sandoz-valsartan-and-hydrochlorothiazide-film-coated-tablets 2023-11-30T11:06:40-05:00 daily 1.0 https://www.novartis.com/us-en/news/form-483-posting-us-food-and-drug-administration-fda-novartis-statement 2023-11-30T11:05:56-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd 2023-12-01T19:32:25-05:00 daily 1.0 https://www.novartis.com/us-en/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique 2025-05-27T03:56:51-04:00 daily 1.0 https://www.novartis.com/us-en/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action 2023-11-30T10:57:12-05:00 daily 1.0 https://www.novartis.com/us-en/news/updated-packaging-now-available-sandimmune-100-mg-blister-packages 2023-11-30T10:55:26-05:00 daily 1.0 https://www.novartis.com/us-en/news/new-policy-related-340b-program 2023-11-30T10:58:49-05:00 daily 1.0 https://www.novartis.com/us-en/news/notice-healthcare-providers-and-entities 2023-11-30T11:00:05-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative 2023-11-30T11:01:33-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-us-response-covid-19 2023-11-30T10:58:03-05:00 daily 1.0 https://www.novartis.com/us-en/news/corrective-action-certain-100-mg-sandimmune-and-neoral-blister-packages-us 2023-11-30T11:04:09-05:00 daily 1.0 https://www.novartis.com/us-en/news/highlighting-unmet-needs-hidradenitis-suppurativa-hs 2023-11-30T10:54:28-05:00 daily 1.0 https://www.novartis.com/us-en/news/collaborating-address-disparities-cancer-screening 2023-11-30T10:53:41-05:00 daily 1.0 https://www.novartis.com/us-en/news/novartis-statement-maximum-fair-price-entresto 2024-08-15T09:31:53-04:00 daily 1.0 https://www.novartis.com/us-en/news/bringing-breakthroughs-more-patients 2025-09-29T14:20:08-04:00 daily 1.0 https://www.novartis.com/us-en/stories/mccourty-twins-friends-shine-spotlight-sickle-cell-disease 2022-03-29T09:28:04-04:00 daily 1.0 https://www.novartis.com/us-en/stories/sourcing-innovation-strategically 2023-04-11T13:47:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/word-street-what-cell-and-gene-therapy 2022-03-29T04:11:13-04:00 daily 1.0 https://www.novartis.com/us-en/stories/day-reflection-novartis 2023-04-11T13:45:43-04:00 daily 1.0 https://www.novartis.com/us-en/stories/shaping-future-sickle-cell-disease 2022-07-21T09:54:08-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-looks-brightest-academic-minds-reimagine-metastatic-breast-cancer-treatment 2023-04-11T13:53:19-04:00 daily 1.0 https://www.novartis.com/us-en/stories/working-together-novartis-fight-covid-19-and-help-people-need 2023-04-11T13:54:40-04:00 daily 1.0 https://www.novartis.com/us-en/stories/reimagining-healthcare-challenging-times-novartis-society-us-report-2020 2023-04-11T13:50:28-04:00 daily 1.0 https://www.novartis.com/us-en/stories/telemedicine-helping-patients-underserved-communities-access-quality-healthcare 2022-03-29T09:16:34-04:00 daily 1.0 https://www.novartis.com/us-en/stories/understanding-heart-health-inequities-during-black-history-month 2023-04-11T13:49:02-04:00 daily 1.0 https://www.novartis.com/us-en/stories/home-app-helps-patients-stay-engaged-and-adherent-vision-monitoring-remotely 2023-04-11T14:03:46-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-health-inequities-starts-looking-within 2023-04-11T14:00:47-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-connecting-and-moving-forward-together 2022-03-29T09:36:09-04:00 daily 1.0 https://www.novartis.com/us-en/stories/know-facts-and-be-advocate-prostate-cancer-awareness-month 2023-09-15T10:46:41-04:00 daily 1.0 https://www.novartis.com/us-en/stories/remembering-mens-health-national-veterans-and-military-families-month 2023-11-14T02:29:35-05:00 daily 1.0 https://www.novartis.com/us-en/stories/associate-volunteers-help-make-2023-multicultural-teen-corporate-mentoring-program-success 2024-07-08T11:16:12-04:00 daily 1.0 https://www.novartis.com/us-en/stories/journey-compassion-from-pharmacy-oncology-sales 2024-07-29T15:34:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/negative-impact-ira-patient-access-innovative-treatments 2024-08-15T09:44:23-04:00 daily 1.0 https://www.novartis.com/us-en/stories/learning-from-experiences-chronic-myeloid-leukemia-cml-community 2026-01-09T12:08:52-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advancing-prostate-cancer-care-a-bold-new-partnership-helping-patients 2025-02-18T09:01:25-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-joins-susan-g-komen-first-its-kind-breast-cancer-policy-coalition 2025-03-12T18:05:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/autoimmune-diseases-disproportionately-impact-women-heres-why-matters 2025-05-13T15:15:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/addressing-elevated-lipoproteina-importance-testing-risk-patients 2025-08-29T10:05:52-04:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-time-100-health-summit-oncology 2025-05-23T09:13:10-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-were-reimagining-cancer-care-next-generation-patient 2025-05-21T11:56:15-04:00 daily 1.0 https://www.novartis.com/us-en/stories/garage-innovation-hub 2025-05-23T09:32:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-katy-patient-turned-advocate-found-her-purpose 2025-06-02T11:34:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-ways-were-innovating-advanced-prostate-cancer-care 2025-06-16T12:20:50-04:00 daily 1.0 https://www.novartis.com/us-en/stories/3-innovative-ways-were-reaching-patients-beyond-our-medicines 2025-06-24T11:26:21-04:00 daily 1.0 https://www.novartis.com/us-en/stories/living-with-sjogrens-disease-one-womans-story 2025-10-01T15:55:17-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoprotein-a-patient-story 2025-08-07T10:01:24-04:00 daily 1.0 https://www.novartis.com/us-en/stories/take-5-reshema-kemps-polanco-novartis-cco 2025-08-29T09:56:58-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-biomedical-research-hub-san-diego-thierry-diagana 2025-09-10T06:24:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-san-diego-research-development-innovation 2025-08-25T15:55:25-04:00 daily 1.0 https://www.novartis.com/us-en/stories/what-are-genetically-targeted-technologies-gtts 2025-09-17T10:31:29-04:00 daily 1.0 https://www.novartis.com/us-en/stories/treating-CML-chronic-myeloid-leukemia 2026-01-27T13:35:01-05:00 daily 1.0 https://www.novartis.com/us-en/stories/advanced-prostate-cancer-social-worker-support 2025-09-17T11:11:54-04:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-katie-mazuk-novartis-us-chief-patient-experience-officer 2025-10-20T10:31:14-04:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-breast-cancer-how-women-feel-breasts 2025-10-03T10:42:06-04:00 daily 1.0 https://www.novartis.com/us-en/stories/high-lipoproteina-explained-what-you-need-know-about-hidden-emerging-indicator-heart-disease 2025-10-09T15:13:20-04:00 daily 1.0 https://www.novartis.com/us-en/stories/how-to-bridge-care-gaps-prostate-cancer 2025-10-22T15:28:33-04:00 daily 1.0 https://www.novartis.com/us-en/stories/veteran-delivers-cancer-treatment-to-patients 2025-11-11T12:38:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-teen-mentoring-program-changing-lives 2025-11-07T09:39:41-05:00 daily 1.0 https://www.novartis.com/us-en/stories/five-questions-eden-wells-chief-insights-and-decision-science-officer-novartis-us 2025-11-13T15:44:09-05:00 daily 1.0 https://www.novartis.com/us-en/stories/community-health-meeting-people-where-they-are 2025-11-17T14:57:57-05:00 daily 1.0 https://www.novartis.com/us-en/stories/innovating-america-new-rlt-manufacturing-site 2026-01-15T14:22:04-05:00 daily 1.0 https://www.novartis.com/us-en/stories/novartis-north-carolina-manufacturing-expansion 2026-01-22T15:26:22-05:00 daily 1.0 https://www.novartis.com/us-en/stories/victor-bulto-and-thierry-diagana-named-2026-time100-health-list 2026-02-11T13:52:10-05:00 daily 1.0 https://www.novartis.com/us-en/stories/whats-next-neuroscience-drug-discovery-conversation-genetic-medicine-head-bryan-laffitte 2026-02-23T12:49:51-05:00 daily 1.0 https://www.novartis.com/us-en/stories/power-precision-using-ai-navigate-future-prostate-cancer-care 2026-02-24T12:35:09-05:00 daily 1.0 https://www.novartis.com/us-en/careers/career-search/job/details/req-10022538-it-strategic-business-partner-usi-salesforce 2024-10-01T15:30:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10042198-qc-analyst 2025-11-25T12:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10029164-rechtsreferendar-mwd-der-rechtsanwaltsstation-oder-im-pflichtwahlpraktikum 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/393466br-patient-access-lead-0 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10042739-equipment-specialist-i 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10042742-qc-specialist-i-analytical 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10049721-japan-program-head-immunology 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047858-product-manager-hf-en-alternance 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10048763-analyst-marketing-services 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10053326-maintenance-technician 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054151-intern-it 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054210-intern-finance 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10044730-tehnolog-proizvodnega-inzeniringa-lokacije-mzd-automation-engineer-multidiscipline-ii-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10003323-produktionsmitarbeiter-mfd-kundl-tirol-austria 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10013454-therapeutic-data-strategy-director 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056628-ed-evidence-generation-ta-head-oncology 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10041453-senior-program-head 2026-02-02T18:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054444-principal-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058488-data-steward 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10051889-senior-principal-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059603-risk-surveillance-lead 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059647-veeva-development-lead 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059989-sales-executive 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050524-senior-clinical-data-scientist 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060203-snr-specialists-data-science-ai-data-digital-it 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060184-senior-specialist-it-solution-delivery-data-digital-it 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060406-snr-specialist-platform-services-data-digital-it 2025-11-01T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10057655-global-medical-affairs-director 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056031-team-lead-engineering-maintenance 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10020584-produktionsmitarbeiter-mwd-schaftenau-tirol-austria 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060710-isotope-project-lead-associate-director-st 2026-01-08T13:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056523-director-ids-functional-reporting 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059402-ldc-data-business-manager-operations 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061532-produktionsmitarbeiter-mwd-befristet 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059560-associate-director-it-solution-delivery-veeva 2026-01-21T18:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060795-director-decision-science-portfolio-2-openings 2026-02-24T13:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062153-engineering-maintenance-technician-iii 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10040602-senior-sap-security-identity-management 2025-11-13T08:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062599-process-expert 2025-12-02T01:32:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062598-process-expert 2025-12-02T01:32:05+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061530-tehnik-v-proizvodnji-farmacevtskih-ucinkovin-mzd 2025-12-04T10:33:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021772-lehre-mechatronik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021773-lehre-elektrotechnik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021766-lehre-labortechnik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064230-lehre-metalltechnik-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064317-reliability-engineer-maintenance-planning-wmd-50-einstellung 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064429-business-insight-strategy-analyst-hf-en-stage 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062668-genai-solution-architect 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064393-ad-access-reimbursement-adar-nps-cv-remote-las-vegas-nv 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064031-clinical-data-engineering-lead 2025-12-03T01:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059083-maintenance-technician-electrical-mwd-schaftenau-tirol 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10055091-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-01-22T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047103-associate-director-ai-tech-lead 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063581-head-erc-china 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058899-visji-specialist-itot-za-avtomatizacijo-proizvodnje-mzd-senior-specialist-itot-manufacturing-automation-engineer-mfd 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065677-facilities-mechanic 2026-02-24T21:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065964-manager-project-management-web-experience 2026-02-20T11:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060374-specialist-laboratorijske-opreme-v-kontroli-kakovosti-mzd-ljubljana-menges 2025-11-21T09:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065443-assoc-dir-ddit-ma-technical-business-analysis 2026-02-03T14:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064325-production-technician 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063514-director-evidence-generation 2025-11-12T11:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066422-maintenance-technician 2025-11-12T17:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066443-skladiscnik-mzd-warehouse-worker-mfd 2026-03-04T14:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065561-early-talents 2025-11-13T13:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056080-associate-rlt-lab-technician 2025-11-18T10:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066972-japan-program-head-oncology 2025-11-17T16:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067189-executive-assistant-coordinator 2025-11-18T13:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067269-operater-iii-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-01-22T08:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066716-senior-manager-internal-audit 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066857-vodja-inzeniringa-lokacije-mzd-site-engineering-head-mfd 2025-11-20T12:33:04+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062369-radioligand-therapies-rlt-director-ecosystem-lead-northern-ca 2026-01-14T04:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066912-ai-search-seo-manager 2026-02-24T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067259-executive-director-crm-innovation-labs 2026-01-07T22:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067285-vice-president-crm-product-management-lead 2025-11-21T15:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067256-executive-director-crm-adoption-enablement 2025-11-20T22:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067258-executive-director-head-crm-experience-design 2025-11-21T16:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066861-senior-manager-field-capability-development-spanish-speaker 2026-02-13T08:32:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067260-executive-director-crm-product-strategy 2025-11-21T16:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066049-senior-business-analyst-veeva-clinical-vault 2025-11-21T17:31:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066772-engineering-specialist 2025-12-01T22:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067456-head-legal-investigations-china 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067633-manager-data-visualization-design 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067523-snr-specialist-itot-business-services-solutions-delivery 2025-12-19T13:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061108-patient-safety-group-manager 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067249-vodja-kakovosti-mzd-site-quality-head-mfd 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067455-senior-manager-cgt-itotautomation 2026-03-04T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064030-senior-engineer-automation 2026-01-08T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067824-data-steward-en-alternance 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067823-po-outils-canaux-digitaux-data-en-alternance 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067826-stage-ingenieur-data 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068192-production-lead 2025-12-04T16:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067997-strategy-manager 2025-12-31T09:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067047-manufacturing-science-technology-experts 2025-12-05T14:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067046-engineering-experts 2025-12-05T14:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067049-supply-chain-experts 2025-12-05T14:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067048-manufacturing-experts 2025-12-05T14:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068294-associate-director-global-publications-foundational-content 2025-12-08T11:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068284-chef-de-produit-confirme-hf 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061972-business-workstream-lead-ldc-lean-digital-core-gmt 2026-01-26T10:32:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068201-quality-manager 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068017-vodja-validacij-mzd-validation-lead-mfd 2026-02-04T12:32:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10021760-lehre-chemieverfahrenstechnik-mfd-de-de 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065531-technical-steward-mwd-de-de 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10051988-banco-de-talentos-para-consultores-tecnicos-es-es 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059703-banco-de-talentos-para-pessoas-com-deficiencia-pcd-es-es 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10007713-alternant-controle-de-gestion-bpa-fr-fr 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066540-associate-or-manager-japan-program-clinical-head-ja-jp 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061501-associate-qa-officer-operations-ja-jp 2025-12-09T13:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10056779-civil-engineer-nl-nl 2026-01-27T22:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067469-qa-manager-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062400-tehnolog-proizvodnih-procesov-mzd-process-expert-mfd 2026-01-16T07:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068233-director-genetic-toxicology-expert 2025-12-10T12:31:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067295-chef-de-produit-junior-en-stage-fr-fr 2026-01-21T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10041761-assoc-dir-ddit-apd-ce-architect 2026-02-23T12:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068234-director-genetic-toxicology-expert 2025-12-10T17:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068573-technical-steward-manager-level 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068583-product-specialist 2026-01-05T16:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068156-chef-de-produit-ophtalmologie-en-stage 2026-02-04T11:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068635-neuroscience-area-business-leader-philadelphia-pa 2025-12-11T17:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068636-neuroscience-area-business-leader-boston-ma 2025-12-11T17:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068349-vodja-zagotavljanja-sterilnosti-mzd-sterility-assurance-lead-mfd 2026-01-16T09:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068652-senior-project-engineermanager-level 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068341-visja-odgovorna-oseba-za-sproscanje-zdravil-na-trg-mzd-senior-qp-mfd 2026-01-05T13:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067250-site-quality-head-ds-huningue 2025-12-12T14:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067629-senior-expert-science-technology-iii-prd 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10049041-onderhoudstechnieker-filling-bio 2025-12-15T12:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068410-senior-expert-human-factors-engineering 2025-12-22T10:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066763-validation-lead 2025-12-15T22:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063806-clinical-development-director-japan 2025-12-16T07:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066741-senior-principal-statistical-programmer 2025-12-16T17:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10057551-medical-director-non-malignant-hematology-remote 2025-12-16T22:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068690-manufacturing-specialist-weekend-night-shift 2026-01-07T22:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068696-2-x-production-technician-weekend-days 2025-12-17T05:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068643-area-sales-manager 2025-12-17T08:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068590-senior-technical-steward-medical-devices 2025-12-19T20:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068691-shift-supervisor-weekend-days 2025-12-17T15:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068437-senior-manager-asset-management-reliability-engineering 2026-01-22T16:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068551-senior-expert-engineering-packaging-design-manager 2026-02-13T13:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067860-technical-transfer-lead-medical-device-mfd 2025-12-18T12:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069000-visji-ekspert-mednarodne-trgovine-mzd-senior-international-trade-expert-mfd 2026-01-23T13:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068862-quality-experts 2025-12-18T15:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068943-ta-head-cardiovascular-renal-metabolic 2025-12-19T09:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068836-senior-global-gcppv-auditor 2025-12-19T11:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068803-koordinator-sprememb-potiskane-ovojnine-mzd-artwork-change-coordinator-mfd 2025-12-19T14:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069041-vodja-upravljanja-kakovosti-operacije-mzd-qa-operations-lead-mfd 2026-01-15T13:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068139-senior-expert-engineering-assembly-medical-device 2025-12-21T23:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068431-expert-engineering-medical-device-development 2025-12-21T23:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068816-vodja-tehnoloskih-prenosov-mzd-technical-transfer-lead-mfd 2026-02-04T12:32:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069134-tehnolog-proizvodnih-procesov-mzd-process-expert-mfd 2025-12-22T13:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062245-director-integrated-field-insights-analytics 2026-01-20T05:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069093-quality-assuranceqa-operations-specialist 2025-12-26T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069096-quality-assuranceqa-operations-specialist 2025-12-26T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069097-qa-operations-supervisor 2025-12-26T16:31:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068777-project-qa-lead 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067889-senior-specialist-automation-engineer 2025-12-30T17:31:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068823-category-manager-medical-affairs-dev-procurement 2026-02-27T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061804-value-access-lead 2026-03-06T02:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069203-sales-representative-north 2026-01-02T08:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068209-head-trade 2026-01-05T14:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069078-private-marketout-pocket-product-manager 2026-01-05T14:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063537-info-specialist-literature-intelligence 2026-01-05T05:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065347-global-monitoring-functional-excellence-lead 2026-01-12T11:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065481-global-monitoring-functional-excellence-director 2026-01-12T11:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10047028-director-business-applications-ai-products 2026-01-06T19:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069223-principal-senior-principal-biostatistician 2026-01-06T21:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067442-director-therapeutic-area-medical-strategy-execution-rlt 2026-01-26T15:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069222-associate-director-biostatistics 2026-01-07T01:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068829-production-lead-weekend-days 2026-01-07T05:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068697-production-technician-weekend-nights 2026-01-07T06:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069051-head-corporate-comms 2026-01-07T08:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069282-material-coordinator 2026-01-08T09:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069345-associate-director-statistical-programming 2026-01-09T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069343-senior-principal-statistical-programmer 2026-01-09T17:31:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069387-cardiovascular-territory-account-specialist-greensburg-pa 2026-01-09T21:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064078-product-manager-drupal 2026-01-21T05:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067871-engineering-evergreen 2026-01-12T10:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069404-enterprise-security-architect-digital-workspace 2026-01-15T09:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067571-senior-business-analyst 2026-01-12T13:31:09+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069499-senior-principal-biostatistician 2026-01-13T16:31:07+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069498-associate-director-biostatistics 2026-01-13T11:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067354-manager-web-and-campaign-tagging 2026-03-05T12:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069438-kierownik-ds-kluczowych-klientow-kardiologia-wojewodztwo-lubelskie 2026-01-13T12:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069584-radioligand-therapies-rlt-director-ecosystem-lead-southern-ca 2026-01-14T02:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069074-ekspert-upravljanja-zivljenjske-krivulje-izdelka-mzd-lifecycle-implementation-expert-mfd 2026-01-15T09:30:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068041-market-brands-manager 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066742-assoc-director-statistical-programming 2026-02-12T13:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069668-cardiovascular-territory-account-specialist-bowling-green-ky 2026-01-15T15:31:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069751-tehnolog-proizvodnega-inzeniringa-mzd-engineer-multidiscipline-ii-mfd 2026-01-16T12:32:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065710-kierownik-ds-kluczowych-klientow-kardiologia-rybnik-czestochowa-kedzierzyn-kozle 2026-01-16T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066986-legal-intern 2026-01-23T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069763-projektni-vodja-upravljanja-zivljenjske-krivulje-izdelka-mzd-life-cycle-manager-mfd 2026-01-16T17:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069578-hse-technician-isotopes 2026-01-16T22:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068064-portfolio-account-specialist-oncology-vic-part-time 2026-01-18T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069712-tehnolog-proizvodnih-procesov-mzd-process-expert-mfd 2026-01-19T09:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10053523-specialist-upravljanja-kakovosti-za-podrocje-skladnosti-racunalniskih-sistemov-qa-ecompliance-specialist 2026-01-19T12:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063715-director-evidence-generation 2026-01-19T14:33:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069735-qc-manager 2026-01-19T17:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069927-senior-statistical-programmer 2026-01-20T02:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069927-senior-statistical-programmer-ja-jp 2026-01-20T02:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066394-sr-manager-ai-innovation-reporting 2026-02-10T08:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068250-business-insight-manager 2026-01-23T14:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069135-qc-analyst-ii-aseptic-processing 2026-01-20T08:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069822-administrative-assistant 2026-01-20T14:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067812-customer-engagement-specialist-ru-ru 2026-01-20T13:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068596-qualification-engineer-ru-ru 2026-01-20T13:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069362-director-oncology-translational-research 2026-01-20T17:32:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063222-director-principal-consultant 2026-02-26T22:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069998-country-president-levant 2026-01-21T12:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069973-packaging-specialist-weekends-night-shift 2026-01-21T16:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069576-cardiovascular-territory-account-specialist-puerto-rico 2026-01-21T19:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069834-cardiovascular-territory-account-specialist-scottsdale-az 2026-01-21T19:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069732-executive-director-access-reimbursement-advanced-platforms 2026-01-21T21:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067194-manager-scientific-writing 2026-01-22T12:33:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070079-production-technician 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069743-head-portfolio-strategy-operations-neuroscience-gene-therapy 2026-01-26T21:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065124-director-policy-ja-jp 2026-01-23T03:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065122-senior-lead-or-lead-public-affairs-ja-jp 2026-01-23T03:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065125-director-social-impact-novartis-foundation-japan-promotion-science-ja-jp 2026-01-23T03:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066235-senior-territory-business-executive 2026-02-12T12:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069597-validation-lead-mfd-de-de 2026-02-05T11:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069836-cardiovascular-territory-account-specialist-flint-mi 2026-01-23T17:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068557-estagio-em-direito-tributario-pt-br 2026-01-23T23:32:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10060901-sr-specialist-genai-engineer 2026-01-26T10:32:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070132-global-clinical-operations-sso-hong-kong-manager 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069390-expert-science-technology-ii 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069949-senior-country-quality-specialist 2026-01-26T12:33:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058985-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd 2026-02-04T13:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065793-communications-governance-support-web-digital-optimization 2026-01-26T15:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059264-manager-implementation-planning-experience-design 2026-01-26T15:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070032-learning-delivery-manager 2026-02-25T15:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070033-change-planning-manager 2026-01-26T15:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066689-mechatroniker-fur-abfullung-und-visuelle-inspektion-mfd 2026-01-28T08:31:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070332-mechaniker-fur-abfullung-und-visuelle-inspektion-mfd 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070063-buyer-mandarin-speaker-zh-cn 2026-01-29T02:34:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070223-allergy-territory-account-specialist-sacramentofresno 2026-01-29T15:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070070-country-promotion-manager-cardiology 2026-02-03T16:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070268-key-account-manager-hematologia-lubelskie-podkarpackie-swietokrzyskie 2026-01-29T17:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068634-medical-information-agent 2026-02-25T21:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070353-principal-scientist-ii 2026-01-29T23:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070180-maintenance-technician 2026-01-30T02:32:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067898-site-it-specialist 2026-01-30T02:32:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068813-manager-scientific-writing 2026-01-30T10:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065856-product-specialist 2026-02-03T08:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069993-sales-executive-taichung 2026-02-26T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070499-senior-principal-statistical-programmer 2026-01-30T13:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070390-principal-statistical-programmer 2026-01-30T13:33:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070048-neuroscience-territory-account-specialist-new-orleans 2026-01-30T15:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069719-medical-science-liaison-msl-cardiometabolic-south-texas-remote 2026-01-31T01:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070451-regional-director-msls-onc-radioligand-therapies-south-east-region-atl-remote 2026-02-11T23:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070657-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070571-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070661-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070651-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070663-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070563-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070564-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070553-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070700-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070594-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070625-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070614-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070783-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070620-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070725-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070587-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070731-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070639-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070795-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067449-field-product-specialist-oncology-hcm 2026-02-02T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070825-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070782-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070704-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070856-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070818-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070722-project-manager-central-platform-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070807-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070890-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070874-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-de-de 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-es-es 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-fr-fr 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-it-it 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-ja-jp 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-nl-nl 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-ru-ru 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-tr-tr 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-zh-cn 2026-02-02T11:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070666-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070932-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069826-process-expert-biove 2026-02-02T13:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070561-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065292-scientist-drug-product-development-senior-expert-science-technologymfd 2026-02-02T17:33:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070671-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070107-neuroscience-territory-account-specialist-grand-rapids-mi 2026-02-02T19:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070105-neuroscience-territory-account-specialist-detroit-s 2026-02-02T19:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070743-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070735-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070744-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070747-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070764-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070745-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070220-supply-chain-specialist 2026-02-27T22:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070762-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070971-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070637-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070654-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071129-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070726-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071131-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071032-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071114-regional-hcsp-manager 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070035-ekspert-tehnologije-izdelkov-mzd-product-steward-mfd 2026-02-03T08:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070997-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070409-tehnolog-bioprocesov-mzd-process-expert-mfd 2026-02-03T09:33:51+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071103-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070297-ekspert-upravljanja-kakovosti-operacije-mzd 2026-02-03T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070942-analyst-clinical-label-management 2026-02-24T12:32:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070999-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071024-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-de-de 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-es-es 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-fr-fr 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-it-it 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070486-associate-or-manager-phad-japan-ja-jp 2026-02-03T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-ja-jp 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-nl-nl 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-ru-ru 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-tr-tr 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-zh-cn 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070296-packaging-specialist 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070920-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070723-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070616-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070419-country-promotion-manager-immunology 2026-02-12T20:33:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071009-clinical-development-medical-director-cdmd-neuroscience 2026-02-03T16:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070857-quyushichangzujingli 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070542-assistante-de-direction-senior-affaires-medicales-hf-fr-fr 2026-02-16T12:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069506-director-crm-product-owner-3-positions 2026-02-11T17:31:57+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069789-director-business-planning-strategy 2026-02-13T13:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063228-senior-manager-public-affairs 2026-02-04T00:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-de-de 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-es-es 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-fr-fr 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-it-it 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-ja-jp 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-nl-nl 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-ru-ru 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-tr-tr 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071101-brand-manager-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-zh-cn 2026-02-04T03:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070484-sales-representative-hematology 2026-02-04T05:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070940-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070902-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071256-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071259-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070373-senior-expert-science-technology 2026-02-24T12:32:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070838-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067356-analyst-data-governance-martech-product-management 2026-02-04T08:32:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070837-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070698-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071230-logistics-manager 2026-02-04T10:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068274-assistante-chef-de-produit-cancer-du-sein-en-stage-fr-fr 2026-02-04T10:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071266-senior-project-managerlocal-platform-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-de-de 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071281-business-insight-strategy-supervisor 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070283-production-support-engineer-mfd 2026-02-11T06:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-es-es 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-fr-fr 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-it-it 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-ja-jp 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-nl-nl 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-ru-ru 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-tr-tr 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071201-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-zh-cn 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070450-head-us-risk-management-product-safety-risk-evaluation-and-mitigation-strategies-rems 2026-02-04T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070454-senior-administrative-assistant-es-es 2026-02-04T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070884-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071264-medical-advisor 2026-02-05T03:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071258-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071407-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070567-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071160-study-director-community-lead 2026-02-27T16:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071317-engineer-automation 2026-02-05T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067192-senior-associate-scientific-writing 2026-02-05T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070943-qa-compliance-expert-sampling-and-manufacturing-mfd 2026-02-05T13:32:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071446-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-de-de 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-de-de 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071248-gaojidaqujingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-es-es 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-es-es 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-fr-fr 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-fr-fr 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-it-it 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-it-it 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-ja-jp 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-ja-jp 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-nl-nl 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-nl-nl 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-ru-ru 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-ru-ru 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-tr-tr 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-tr-tr 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-zh-cn 2026-02-05T12:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071168-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071055-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070343-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-zh-cn 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071213-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070701-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070660-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070923-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071217-senior-expert-medical-device-analytical-representative-mfd 2026-02-05T13:32:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070589-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071367-central-monitor 2026-02-05T15:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071049-kierownik-ds-kluczowych-klientow-kardiologia-wojewodztwo-mazowieckie 2026-02-05T17:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071371-key-account-manager-rlt-mazowieckie-podlaskie-lubelskie-swietokrzyskie-podkarpackie 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071370-lead-central-monitor 2026-02-05T15:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070452-associate-director-fair-market-value-bona-fide-service-fee-fmv-bfsf 2026-02-05T15:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071483-head-qa-ops-and-compliance 2026-02-17T19:32:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071437-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070737-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071438-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070791-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071435-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070787-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070929-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071506-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070935-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070922-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T16:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071460-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070689-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070834-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070881-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071479-brand-manager-ipa 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071477-associate-director-ipa 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071184-strategy-manager 2026-02-06T11:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071020-global-it-sourcing-manager-it-software 2026-02-06T12:32:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070678-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070990-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070650-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070858-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065854-director-launch-excellence 2026-02-06T15:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070152-principal-scientist-biomarker-assay-development-bench-scientist 2026-02-06T16:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071397-process-improvement-manager-operational-excelence 2026-02-06T19:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070236-ad-cell-therapy-operations-manager-new-york-tri-state 2026-02-06T20:32:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071452-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071401-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-de-de 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071414-senior-regulatory-affairs-manager 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-es-es 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-fr-fr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-it-it 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-ja-jp 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-nl-nl 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-ru-ru 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-tr-tr 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071623-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071277-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059749-clinical-development-director-renal 2026-02-09T10:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071633-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071039-director-strategic-projects-lead 2026-02-09T12:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071626-field-product-specialist-cardiovascular-hcm 2026-02-09T14:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070092-global-head-ai-and-data-privacy-legal 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10052215-senior-clinical-development-medical-director-renal 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070702-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-09T15:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071199-medical-representative-disease-area-specialist 2026-02-10T09:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071393-supply-chain-consultant-vaga-afirmativa-pcd-pt-br 2026-02-09T17:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065757-director-marketing-program-governance 2026-02-09T20:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-10T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-de-de 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-es-es 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-fr-fr 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-it-it 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-ja-jp 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-nl-nl 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-ru-ru 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-tr-tr 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-zh-cn 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065816-associate-director-web-analytics 2026-02-10T12:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071709-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-10T14:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071521-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-10T14:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065811-associate-director-ai-innovation-lab-martech 2026-02-10T15:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065814-associate-director-innovation-lab-xr-metaverse 2026-02-10T15:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071387-director-marketing-strategy-multiple-sclerosis 2026-02-11T02:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071611-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T02:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071710-digital-content-operation-manager 2026-02-11T03:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-de-de 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-es-es 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-fr-fr 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-it-it 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-ja-jp 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-nl-nl 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-ru-ru 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-tr-tr 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-zh-cn 2026-02-11T04:32:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-de-de 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-es-es 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-fr-fr 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-it-it 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-ja-jp 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-nl-nl 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-ru-ru 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-tr-tr 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-zh-cn 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071312-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071522-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071622-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T12:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070090-data-analytics-and-tool-manager 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071842-gaojiquyushichangjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063733-associate-director-congress-operations 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070659-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070965-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-11T13:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071298-skrbnik-osnovnih-podatkov-materialov-mzd-site-master-data-expert-mfd 2026-02-11T16:32:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071671-principal-project-engineer 2026-02-11T21:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071843-quyushichangjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T04:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071270-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T05:32:01+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071836-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071164-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-de-de 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-de-de 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071691-production-technician-produktionmitarbeiter-mwd 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-es-es 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-es-es 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-fr-fr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-fr-fr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-it-it 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-it-it 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-ja-jp 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-ja-jp 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-nl-nl 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-nl-nl 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-ru-ru 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-ru-ru 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-tr-tr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-tr-tr 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-zh-cn 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-zh-cn 2026-02-12T09:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-de-de 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-de-de 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-es-es 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-es-es 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-fr-fr 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-fr-fr 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-it-it 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-it-it 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-ja-jp 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-ja-jp 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071654-cluster-category-manager-general-ja-jp 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-nl-nl 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-nl-nl 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-ru-ru 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-ru-ru 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-tr-tr 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-tr-tr 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070906-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070904-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071040-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070996-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-12T10:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070330-supply-chain-dispatch-shipping-expert 2026-02-12T11:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071629-facility-manager 2026-02-12T11:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070328-supply-chain-customer-service-agent 2026-02-12T11:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071628-business-analyst-dap-par 2026-02-12T12:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070255-senior-hse-expert 2026-02-12T12:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071603-lead-congress-management-association-relations 2026-02-12T19:34:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066626-lead-consultant 2026-02-12T21:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071872-neuroscience-area-business-leader-ohin 2026-02-12T22:33:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070143-senior-principal-scientistin-vivo-pharmacology-lab-head-80-100 2026-02-12T23:34:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067624-immunology-sales-representative-ja-jp 2026-02-13T04:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069056-territory-business-executive-institutional-sales-chennai 2026-02-13T08:32:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071934-territory-business-executive-chennai 2026-02-13T09:34:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-de-de 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071852-senior-manager-field-capability-development-german-speaker 2026-02-13T08:32:54+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-es-es 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-fr-fr 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-it-it 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-ja-jp 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-nl-nl 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-ru-ru 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-tr-tr 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-zh-cn 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067854-sr-manager-marketing 2026-02-25T06:33:19+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071532-priloznosti-za-iskalce-prve-zaposlitve-v-novartisu-v-sloveniji 2026-02-13T11:33:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072076-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-lingshou-zh-cn 2026-02-13T11:33:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072068-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071935-facility-coordinator-french 2026-02-23T13:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071784-facility-coordinator-german 2026-02-23T13:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071659-facility-coordinator-spanish 2026-02-23T13:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071791-clinical-operations-country-head-france 2026-02-16T18:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069835-director-corporate-affairs-academy 2026-02-17T02:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071500-first-line-sales-manager-immunology 2026-02-16T09:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072141-medical-safety-physician 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071828-qc-analyst-ii-labortechniker-mwd 2026-02-16T09:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-16T09:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071412-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-24T04:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071433-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-16T09:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066155-executive-director-hematology-cls 2026-02-16T10:31:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071977-expert-science-technology-radiochemistry 2026-02-16T12:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072120-associate-director-it-business-partner-customer-engagement 2026-02-16T12:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072078-senior-expert-science-technology-radiochemistry 2026-02-16T12:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070121-senior-clinical-development-director-cardiovascularmetabolic 2026-02-17T16:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070457-record-report-manager-es-es 2026-02-16T22:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072235-maseeraty-graduate-program-medical-affairs-associate 2026-02-17T08:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071948-qc-specialist-ii 2026-02-17T10:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070145-skladiscnik-i-mzd 2026-02-17T10:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071895-site-hse-head 2026-02-17T15:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071590-business-operations-lead-external-innovation 2026-02-17T15:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064498-treasury-cash-management-senior-payment-specialist-us-ma-es-es 2026-02-17T15:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070456-record-report-sr-specialist-es-es 2026-02-17T15:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070049-warehouse-technician-ii 2026-02-17T16:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069563-customer-engagement-associate-oncologia 2026-02-17T16:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050665-assoc-dir-ddit-ies-hpc-infrastructure-sr-engineer 2026-02-17T17:31:31+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072223-global-finance-master-data-senior-specialist 2026-02-18T01:32:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071538-senior-analyst-bsi-forecasting 2026-02-18T09:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070414-rs-function-management-strategic-partnerships-lead 2026-02-18T10:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071746-senior-study-leader 2026-02-18T15:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072062-dermatology-territory-account-specialist-madison-wi 2026-02-18T15:31:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072300-novartis-turkiye-summer-internship-program-2026-head-office-atasehir-factory-kurtkoy 2026-02-19T06:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071793-area-reimbursement-lead-ky-mi-oh-wv-territory-remote 2026-02-18T16:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069029-associate-director-case-management 2026-02-19T22:31:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070002-senior-clinical-development-medical-director-cardiovascularmetabolic 2026-02-19T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071698-clinical-scientific-expert-i 2026-02-18T18:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072219-director-market-access-strategy-ta-onc 2026-02-18T22:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067931-radioligand-therapies-rlt-associate-director-priority-accounts-chicago 2026-02-18T23:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071998-ed-payer-pricing-strategy 2026-02-18T23:31:21+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071999-qc-microbiologist 2026-02-19T02:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10057720-development-regulatory-affaires-kaifayaoshi-ja-jp 2026-02-19T03:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071849-global-head-ai-and-data-privacy-legal 2026-02-19T04:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069001-operater-vizualne-kontrole-mdz-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066557-clinical-development-medical-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066369-vzorcevalec-mzd-sampling-operator-mfd-sl-si 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067679-head-ddit-china-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070621-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070322-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070572-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070892-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070718-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070939-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070974-senior-brand-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070993-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070969-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070936-medical-science-liaison-csu-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070966-medical-science-liaison-bc-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070173-medical-science-liaison-bc-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071152-gaojiquyushichangjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071147-gaojidaqujingli-sl-si 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070852-gaojidequjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071134-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070877-senior-brand-manager-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071263-senior-sales-executive-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071135-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070861-senior-brand-manager-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071284-senior-brand-manager-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070869-guangkuoshichangjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070870-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071274-e-commerce-manager-o2o-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070821-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071249-marketing-director-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071255-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070868-guangkuoshichangjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071273-e-commerce-manager-ali-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071251-key-account-executive-sl-si 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071400-senior-sales-executive-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070708-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071166-gaojiquyushichangjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071439-sr-business-insight-strategy-manager-sl-si 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071469-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070880-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070882-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071468-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071505-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071473-gaojidequjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071474-gaojidequjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071618-senior-brand-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071601-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071636-sr-manager-retail-marketing-sl-si 2026-02-28T03:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071729-associate-field-operation-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071826-senior-brand-manager-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069141-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071742-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071846-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071871-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071825-medical-science-liaison-bc-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071267-guangkuoshichangjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071509-guangkuoshichangjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071824-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071533-gaojidequjingli-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071882-specialist-upravljanja-kakovosti-za-podrocje-skladnosti-racunalniskih-sistemov-qa-ecompliance-specialist-mfd-sl-si 2026-03-06T09:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071946-senior-marketing-manager-sl-si 2026-02-24T03:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067472-operater-na-pripravisterilizaciji-ali-polnjenju-mzd-sl-si 2026-02-19T07:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069227-expert-science-technology-oligonucleotidespeptide-therapeutics 2026-03-05T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10057113-head-legal-emerging-markets 2026-02-19T10:31:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069577-global-head-customs-and-trade-compliance-rlt-mfd 2026-02-19T13:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072251-laboratorijski-analitik-mzd 2026-02-25T12:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072242-po-people-partner 2026-02-19T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071090-technician-ii-instrumentation-and-controls 2026-02-19T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072237-senior-manager-international-finance 2026-02-19T14:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070379-qc-analyst-fr-fr 2026-02-19T15:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071775-facility-manager-mfd 2026-02-27T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066032-manager-integrated-field-insights-analytics 2026-03-04T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069375-sourcing-manager-medical-affairs 2026-02-27T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071959-finance-rotation-program 2026-02-20T09:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071279-global-it-sourcing-manager-it-services 2026-02-20T10:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059805-assoc-dir-ddit-ies-cloud-engineering 2026-02-20T11:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071228-qc-analyst-fr-fr 2026-02-20T11:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072253-ast-specialist-mzd-ast-specialist-mfd 2026-02-20T12:31:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072254-visji-ast-specialist-mzd-senior-ast-specialist-mfd 2026-02-27T11:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072428-tehnik-vzdrzevanja-v-proizvodnem-inzeniringu-mfd-maintenance-technician-manufacturing-engineering-mfd 2026-02-20T13:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10054353-patient-centered-outcomes-hta-ta-director 2026-02-20T14:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070501-central-monitor 2026-02-27T07:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072463-sr-people-partner-er-lead 2026-02-23T07:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071993-manager-solutions-activation-automation 2026-02-23T07:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069632-laboratorijski-analitik-mzd 2026-02-23T11:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072578-technical-transfer-lead-wmd 2026-02-23T12:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072270-cse-group-head 2026-02-23T12:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072337-materials-operator 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072266-mehanik-mzd-equipment-specialist-mfd-sl-si 2026-02-23T14:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071795-oncology-specialist-rlt-prostate-salt-lake-city 2026-02-23T16:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071967-qc-analyst 2026-02-27T08:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072335-trial-vendor-senior-manager 2026-02-23T17:31:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072464-trial-vendor-senior-manager 2026-03-02T16:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072593-associate-director-us-advisor-privacy-ai-ethics-risk-compliance 2026-02-23T19:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072258-manager-rwe-research-analytics 2026-02-23T19:31:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071466-head-neuromuscular-diseases-translational-medicine 2026-02-23T20:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071048-mehanik-mzd 2026-02-23T20:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072373-senior-analyst-brand-analytics 2026-02-23T20:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072256-senior-rwe-research-analyst 2026-02-23T20:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072397-dermatology-area-business-leader-san-francisco-ca 2026-02-23T23:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072494-qc-manager 2026-02-23T23:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072272-sales-value-manager-specialty-care 2026-02-23T23:31:52+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-de-de 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-es-es 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-fr-fr 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-it-it 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-ja-jp 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-nl-nl 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-ru-ru 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-sl-si 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-tr-tr 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071941-medical-science-liaison-csu-zh-cn 2026-02-24T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067097-associate-director-real-world-evidence 2026-02-24T06:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-de-de 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069689-senior-specialist-data-science-ai-big-data-engineer 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-es-es 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-fr-fr 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-it-it 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-ja-jp 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-nl-nl 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-ru-ru 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-sl-si 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-tr-tr 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069688-senior-specialist-data-science-ai-zh-cn 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071416-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-24T09:33:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072637-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072287-site-quality-head-mwd 2026-02-24T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066910-ai-search-seo-analyst 2026-02-24T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066397-subject-matter-expert-it-it 2026-02-24T11:32:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071085-senior-supply-chain-specialist-mfd 2026-02-24T12:32:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063697-global-medical-director-cell-gene-therapy 2026-02-24T12:32:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072384-consultant-en-ventes-specialisees-neuroscience-est-du-quebec 2026-03-02T20:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072384-consultant-en-ventes-specialisees-neuroscience-est-du-quebec-fr-ca 2026-03-02T20:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072500-global-quality-controlanalytical-science-and-technology-head 2026-02-24T15:33:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072526-vp-ma-transactions 2026-02-25T21:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072527-vp-ma-transactions 2026-02-25T21:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-de-de 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072536-sourcing-manager-refs-lacan-temporary 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-es-es 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-fr-fr 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-it-it 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-ja-jp 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-nl-nl 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-ru-ru 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-sl-si 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-tr-tr 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071503-field-force-representative-zh-cn 2026-02-24T17:33:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072547-allergy-area-business-leader-pacific-northwest 2026-02-24T18:33:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072613-material-planner-buyer 2026-02-24T20:33:03+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072473-ekspert-upravljanja-kakovosti-i-mzd-qa-senior-manager-mfd 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071301-senior-scientist-small-scale-oligonucleotide-synthesis-80-100 2026-02-24T23:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071560-principal-scientist-midlarge-scale-oligonucleotide-synthesis-xrna-therapeutics 2026-02-24T23:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065751-ad-learning-delivery 2026-02-25T00:33:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072646-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072061-site-utility-lead 2026-02-25T03:34:50+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072644-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072629-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-25T04:33:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071663-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-25T04:33:14+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070258-financial-planning-analysis-manager 2026-02-25T05:33:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-de-de 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-es-es 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-fr-fr 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-it-it 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-ja-jp 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-nl-nl 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-ru-ru 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-sl-si 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-tr-tr 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072726-marketing-assistant-zh-cn 2026-02-25T07:33:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072654-whatfix-lead 2026-02-25T08:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072563-senior-product-specialist 2026-02-26T06:31:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072414-gcp-compliance-manager-emea-hub 2026-02-25T08:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072758-senior-study-leader 2026-02-25T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069704-rep-lead-region-europe 2026-02-25T10:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070814-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-25T12:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072751-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-25T12:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071950-specialist-kontrole-kakovosti-mzd 2026-02-25T13:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072434-manager-ai-business-enablement 2026-02-25T13:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065776-associate-clinical-sourcing-manager 2026-02-27T11:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072448-manager-decision-intelligence-solutionist 2026-02-25T13:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072454-manager-innovation-lab-learning-training-assets-delivery-mava 2026-02-25T14:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072114-quality-assurance-manager-ldc 2026-02-25T14:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072452-manager-innovation-specialist-ai 2026-02-25T14:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071596-senior-scientific-engagement-program-manager 2026-02-25T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072450-head-legal-romania 2026-02-25T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071594-scientific-engagement-program-manager 2026-02-25T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072650-senior-manager-intellectual-property-and-legal-innovation-projects-system 2026-02-25T17:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072478-manager-integrated-evidence-excellence-coordination 2026-02-25T18:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070086-technisch-operator-packaging-visco-elastics 2026-02-25T22:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-de-de 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-es-es 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-fr-fr 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-it-it 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-ja-jp 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-nl-nl 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-ru-ru 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-sl-si 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-tr-tr 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072365-assoc-dir-information-security-business-continuity-zh-cn 2026-02-26T00:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072539-strategic-access-manager 2026-02-26T01:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072787-validation-lead 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072759-gaojiquyushichangjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072752-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-26T03:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069230-sr-procurement-ai-analytics-lead 2026-02-26T06:31:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072667-associate-director-call-plan-alignment 2026-02-26T07:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072671-associate-director-ic-platform-rollout 2026-03-06T06:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072669-associate-director-ic-design-diagnostics 2026-03-06T06:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10050992-betriebswerker-maschinenbediener-bereich-herstellung-3-schichten-mwd-wehr-deutschland 2026-02-26T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071219-qc-analyst-ii-de-de 2026-02-26T09:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072682-specialist-kontrole-kakovosti-mzd 2026-02-26T10:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072568-global-it-category-ai-transformation-manager 2026-02-26T10:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070095-laboratorijski-analitik-mzd 2026-02-26T11:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072504-manufacturing-specialist-ja-jp 2026-02-26T11:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069839-senior-legal-counsel-immunology-international 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065861-itot-senior-specialist-manufacturing-services-automation-engineer 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072816-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-26T12:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10059478-executive-director-human-insights-and-analytics 2026-02-26T14:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072471-site-partnership-manager-study-and-site-operations-12-month-fixed-term-contract 2026-02-26T14:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072744-site-hse-head-sasayama 2026-02-26T14:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068945-associate-director-solution-delivery-manufacturing-execution-systems 2026-02-26T14:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072813-hse-specialist-rlt-sasayama 2026-02-26T14:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072812-specialty-sales-consultant-neurosciences-montreal-south-shore-quebec-center 2026-03-02T20:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072812-consultant-en-ventes-specialisees-neurosciences-rive-sud-de-montreal-centre-du-quebec-fr-ca 2026-03-02T20:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071765-recent-bachelormaster-graduate-stockroom-team-global-discovery-chemistry 2026-02-26T18:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068946-senior-manager-critical-infrastructure 2026-02-26T18:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070120-site-mst-head-smo 2026-02-26T19:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070064-neuroscience-ms-territory-account-specialist-los-angeles-south 2026-02-26T19:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072058-bioprocess-engineer-iiiii-dp-pm-shift 2026-02-26T22:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072607-portfolio-account-specialist-vic-west-oncology 2026-02-26T22:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072292-site-quality-head-texas-ad-level 2026-02-26T23:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072553-business-planning-analysis-manager 2026-02-26T23:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072294-site-quality-head-florida-ad-level 2026-02-26T23:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072492-senior-patent-attorney 2026-02-27T02:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072631-gaojidequjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-de-de 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-de-de 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-de-de 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-es-es 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-es-es 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-es-es 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-fr-fr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-fr-fr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-fr-fr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-it-it 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-it-it 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-it-it 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-ja-jp 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-ja-jp 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-ja-jp 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-nl-nl 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-nl-nl 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-nl-nl 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-ru-ru 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-ru-ru 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-ru-ru 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-sl-si 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-sl-si 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-sl-si 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-tr-tr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-tr-tr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-tr-tr 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072825-medical-science-liaison-immu-zh-cn 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072826-medical-science-liaison-immu-zh-cn 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072821-medical-science-liaison-immu-zh-cn 2026-02-27T06:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062600-vodja-varstva-osebnih-podatkov-ter-skladnosti-na-podrocju-digitalizacije-umetne-inteligence-mzd-head-data-privacy-digital-and-ai-compliance-mfd 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072773-assoc-director-sap-cloud-platform-integration 2026-02-27T09:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072866-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-27T10:31:42+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071662-po-hr-people-partner 2026-02-27T11:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072585-it-sr-business-analyst-customer-engagement 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064380-supply-chain-management-expert 2026-02-27T11:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069612-portfolio-program-management-office-associate-director 2026-02-27T11:31:24+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072391-associate-director-analytics-delivery-lead 2026-02-27T12:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072571-junior-manufacturing-technician 2026-02-27T12:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072898-medical-director-neuroscience-global-medical-affairs 2026-02-27T13:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072896-executive-medical-director-global-medical-affairs-neuroscience 2026-02-27T13:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072381-decision-intelligence-solution-manager-metaverse-augmented-virtual-reality-and-applications 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072380-manager-ai-innovation-lab-learning-and-training-assets-delivery 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065476-ad-engineering-design-construction 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072386-manager-innovation-lab-xr-solutionist 2026-02-27T14:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065729-senior-expert-container-closure-integrity-mfd 2026-02-27T15:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072560-vendor-alliance-lead-associate-director-cardiac-safety-and-diagnostics 2026-02-27T15:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072385-manager-innovation-lab-metaverse-augmented-virtual-reality-and-applications 2026-02-27T15:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070535-associate-director-technology-platforms 2026-02-27T16:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072640-bpa-manager 2026-02-27T16:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072712-associate-director-field-launch-excellence 2026-02-27T19:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072403-director-execution-excellence 2026-02-27T21:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072404-director-transformation-architect-1-2 2026-02-27T21:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072695-associate-director-field-insights-analytics-xportfolio 2026-02-27T22:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072691-associate-director-field-capability-development-innovation 2026-02-27T21:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072545-associate-director-ids-capabilities 2026-02-27T21:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072709-associate-director-execution-excellence-1-2 2026-02-27T22:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072491-director-business-operations 2026-02-27T22:31:34+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072688-associate-director-field-portfolio-early-assets-gtm-analytics 2026-03-02T22:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071764-director-strategy-communications-dsc-immunology-rheumatology-remote 2026-02-27T23:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072908-procurement-intern-wd-zh-cn 2026-02-28T04:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072916-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072912-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-02-28T06:31:20+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070119-head-quality-control 2026-03-02T00:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071250-sr-sales-executive 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073011-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-02T04:31:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068761-senior-analyst-forecasting 2026-03-02T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069171-medical-representative-can-tho 2026-03-02T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061762-field-product-specialist-cardiovascular-and-metabolism-nam-dinh-thai-binh 2026-03-02T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069800-manager-forecasting 2026-03-02T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068718-field-product-specialist-oncology-ha-noi 2026-03-02T05:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070493-associate-expert-science-technology 2026-03-02T06:31:47+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073034-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073010-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-02T07:31:48+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070272-associate-director-field-medical-execution-immunology 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066477-executive-director-renal-international-rare-renal 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072784-specialist-mst-medical-devices 2026-03-05T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070269-associate-director-field-medical-execution-oncology 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070275-associate-director-field-medical-execution-neuroscience 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072815-manager-mst-validation-expert 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070270-associate-director-field-medical-execution-crm 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072856-specialist-mst 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071593-senior-scientific-writer-ii 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072418-payroll-services-senior-expert 2026-03-02T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-de-de 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-de-de 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072948-laboratorijski-analitik-v-mikrobioloskem-laboratoriju-mzd 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-es-es 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-es-es 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-fr-fr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-fr-fr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-it-it 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-it-it 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-ja-jp 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-ja-jp 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-nl-nl 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-nl-nl 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-ru-ru 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-ru-ru 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-sl-si 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-sl-si 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-tr-tr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-tr-tr 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073042-medical-advisor-manager-immu-zh-cn 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073043-msl-manager-immu-zh-cn 2026-03-02T11:31:15+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073066-ra-manager-gdd-oman-omani-national 2026-03-02T12:31:17+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064681-global-regulatory-affairs-associate-director-cardio-metabolic 2026-03-02T13:31:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069934-strategic-assistant-cls 2026-03-02T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069388-director-product-strategy-lead-radioligand-therapy 2026-03-02T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072557-people-organization-people-partner-hr 2026-03-05T17:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070317-study-site-operations-us-country-head-remote 2026-03-02T16:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-de-de 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072169-qa-officer 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-es-es 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-fr-fr 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071740-ast-analyst-fr-fr 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-it-it 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-ja-jp 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-nl-nl 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-ru-ru 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-sl-si 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-tr-tr 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072172-client-service-analyst-zh-cn 2026-03-02T17:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065466-associate-director-biomedical-research-clinical-quality 2026-03-02T18:33:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072943-sr-analyst-payor-access-reimbursement-ia 2026-03-02T19:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072932-manager-payor-access-reimbursement-ia 2026-03-02T19:33:02+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069643-oncology-disease-account-lead-malignant-hematology-charlotte 2026-03-02T21:33:16+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072541-director-customer-engagement-advisor-ethics-risk-compliance 2026-03-02T22:33:11+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073098-supply-operations-specialist 2026-03-02T23:33:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072974-manager-compliance-enablement-and-controls 2026-03-02T23:33:12+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068062-portfolio-account-specialist-oncology-qld-part-time 2026-03-03T00:33:10+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072980-oncology-specialist-breastwomens-cancer-jacksonville 2026-03-03T01:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072981-oncology-sales-specialist-breast-womens-cancer-orlando 2026-03-03T01:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068789-head-public-affairs-taiwan 2026-03-03T02:33:23+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066635-director-product-commercial-assessment-insights 2026-03-03T04:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066636-director-product-commercial-assessment-insights 2026-03-03T04:33:18+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10037580-sr-manager-executive-communications 2026-03-03T06:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072914-dam-librarian 2026-03-03T06:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072906-manager-data-governance 2026-03-03T06:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072905-data-engineering-manager 2026-03-03T06:32:58+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-de-de 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072953-forecasting-head 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-es-es 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-fr-fr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-it-it 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-ja-jp 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-nl-nl 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-ru-ru 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-sl-si 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-tr-tr 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073069-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070985-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073120-medical-advisor-immu-zh-cn 2026-03-03T07:32:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073075-head-people-services-solutions-apac 2026-03-03T08:33:00+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073086-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064625-sr-spec-ddit-ops-itot-service-operational-manager 2026-03-03T09:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072957-business-analyst-marketing-platform-ops-manager-senior-manager 2026-03-03T09:32:49+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070933-gaojidequjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072533-sourcing-manager-facility-management-services-capex 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073057-field-product-specialist-oncology-immunology-hai-phong 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072986-medical-affairs-head 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073051-patient-journey-specialist-hcm 2026-03-03T11:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073059-senior-manager-marketing-platform-operations 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073061-associate-director-web-platforms 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073056-senior-manager-consent-and-preference-management 2026-03-03T18:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073144-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-03T10:32:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073055-value-access-head 2026-03-03T11:32:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073134-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072899-associate-country-qa-operations-core-products 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073137-hse-specialist 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073166-therapeutic-area-partner-leqvio-abu-dhabi-and-alain-crm-ta 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072899-associate-country-qa-operations-core-products-ja-jp 2026-03-03T12:33:08+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072972-regulatory-affairs-associate 2026-03-03T13:32:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071879-global-head-ai-enterprise-transformation 2026-03-03T13:32:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10062738-director-data-analytics-enablement 2026-03-03T14:33:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071756-global-head-ai-enterprise-transformation 2026-03-03T14:33:06+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-de-de 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072519-head-real-estate-portfolio-row 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-es-es 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-fr-fr 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-it-it 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-ja-jp 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-nl-nl 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-ru-ru 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-sl-si 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-tr-tr 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072890-record-report-sr-specialist-zh-cn 2026-03-03T15:32:59+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072874-principal-scientist-compound-hub-lab-leader-compound-management 2026-03-03T17:33:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071377-scientist-analytical-science-and-technology 2026-03-03T18:33:13+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10058909-ed-head-analytics-engineering 2026-03-03T19:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072931-production-process-support-associate 2026-03-03T19:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072800-ed-decision-science-renal-ta-and-us-portfolio-product-strategy 2026-03-03T22:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072887-sales-value-manager-oncology 2026-03-04T01:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071328-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072950-xiaoshoudaibiao-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073128-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071100-gaojidaqujingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073033-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071023-global-quality-innovation-lead 2026-03-04T05:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071108-aggregate-reports-risk-management-analyst 2026-03-04T05:31:32+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072426-expert-engineering-packaging-development-mfd 2026-03-04T07:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073141-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073215-therapeutic-area-partner-breast-cancer-abu-dhabi 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073213-therapeutic-area-partner-hf-htn-abu-dhabi-and-alain 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072817-manager-nabave-tretjih-dobaviteljev-mzd-supply-operations-manager-mfd 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072789-tehnolog-proizvodnih-procesov-ii-mzd-process-expert-ii-mfd 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073163-medical-science-liaison 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071116-head-new-product-international-china 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071769-expert-scientific-writer 2026-03-04T08:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073165-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073170-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071770-senior-scientific-writer-ii 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071927-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073005-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-04T09:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072827-specialist-mbr-designer 2026-03-04T10:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073021-senior-medical-science-liaison-oncology 2026-03-05T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073231-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073238-career-opportunities-engineering 2026-03-04T14:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10064204-senior-patent-litigation-paralegal 2026-03-04T16:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072892-head-international-communications-patient-advocacy 2026-03-04T16:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072221-associate-director-us-market-access-therapeutic-area-strategy-remote 2026-03-04T16:31:22+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073076-refs-managerfacility-manager 2026-03-04T18:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072101-export-finance-manager-technology 2026-03-04T18:31:30+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072698-senior-process-engineer 2026-03-04T19:31:25+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072891-dermatology-territory-account-specialist-albany-ny 2026-03-04T21:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073274-neuroscience-territory-account-specialist-long-island-ny 2026-03-04T22:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073147-early-clinical-development-physician-immunology 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-de-de 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073250-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-es-es 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-fr-fr 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-it-it 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-ja-jp 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-nl-nl 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-ru-ru 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-sl-si 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-tr-tr 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073009-quyushichangjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072632-marketing-director-zh-cn 2026-03-05T04:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072356-associate-director-health-economics-evidence-insights-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072359-associate-director-economic-modelling-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072360-associate-director-health-economics-evidence-synthesis-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072362-associate-director-health-economics-dossier-planning-execution-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072364-director-operations-value-access-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072363-director-health-economics-bsi 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071783-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-05T06:31:26+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073360-gaojidaqujingli 2026-03-05T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072867-product-manager 2026-03-05T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10067026-assoc-dir-ddit-dev-ce-sol-arch 2026-03-05T07:31:33+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-de-de 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072776-clinical-project-manager 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072295-quality-assurance-officer-operations-mwd 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-es-es 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-fr-fr 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-it-it 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-ja-jp 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-nl-nl 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-ru-ru 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-sl-si 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-tr-tr 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071441-gaojidequjingli-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073218-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073362-medical-advisor-neuroscience-zh-cn 2026-03-05T08:31:36+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070306-associate-director-therapeutic-area-oncology-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070312-associate-director-therapeutic-area-immunology-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073366-associate-analyst-quality-operations 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070284-associate-director-therapeutic-area-neurosciences-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070313-associate-director-therapeutic-area-cardiovascular-metabolism-cvm-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070291-associate-director-strategic-ci-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070309-associate-director-therapeutic-area-platformsemerging-technologies-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070311-associate-director-therapeutic-area-renal-enterprise-competitive-intelligence 2026-03-05T09:31:27+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066493-laboratory-systems-technical-specialist 2026-03-05T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10066103-assoc-dir-ddit-ies-cloud-plat-azure 2026-03-05T10:31:38+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-de-de 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072771-postgraduate-quality-compliance 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072511-tl-operational-expert 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-es-es 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-fr-fr 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-it-it 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-ja-jp 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-nl-nl 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-ru-ru 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-sl-si 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-tr-tr 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073156-associate-analyst-quality-operations-zh-cn 2026-03-05T11:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070777-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-05T12:31:44+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10070340-ekspert-tehnologije-izdelkov-mzd-product-steward-mfd 2026-03-05T13:31:45+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071553-medical-lead-rhumatology-en-stage 2026-03-05T14:31:39+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073410-vzorcevalec-mzd-sampling-operator-mfd 2026-03-05T15:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072697-associate-director-heor-product-lead 2026-03-05T15:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072530-value-access-head 2026-03-05T16:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073108-collections-manager-es-es 2026-03-05T16:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071745-qc-analyst-fr-fr 2026-03-05T16:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10055979-associate-director-biotherapeutic-engineering-bioconjugation 2026-03-05T18:31:56+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10044437-threat-hunting-assoc-dir-ddit-isc 2026-03-05T19:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10063033-field-execution-analyst-es-es 2026-03-05T19:31:28+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072228-director-internal-ids-communications 2026-03-05T20:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073277-medical-science-liaison-msl-onc-heme-nyc-north-nj-remote 2026-03-05T21:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072893-senior-administrative-assistant 2026-03-05T22:31:29+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071094-medical-science-liaison-msl-onc-prostate-radioligand-therapies-south-texas-remote 2026-03-05T23:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10072860-executive-director-functional-ai-process-excellence-market-access 2026-03-05T23:31:43+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073074-senior-pipeline-manager 2026-03-06T02:31:55+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071339-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071323-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071170-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071316-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073015-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073375-field-product-specialist-cardiovascular-and-metabolism-hn 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T04:31:35+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10065078-team-head-clinical-label-management 2026-03-06T05:31:41+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071318-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10071928-sr-process-expert 2026-03-06T08:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10068475-sourcing-manager-it 2026-03-06T08:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073201-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T08:31:46+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10069909-manager-medical-data-enablement 2026-03-06T09:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073374-product-specialist-dermatology-sabah-and-sarawak 2026-03-06T09:31:53+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10061610-payroll-expert 2026-03-06T10:31:40+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073229-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn 2026-03-06T11:31:37+00:00 daily 0.5 https://www.novartis.com/us-en/careers/career-search/job/details/req-10073054-senior-legal-counsel-business-operations-launch-and-activation 2026-03-06T11:31:37+00:00 daily 0.5